Patents by Inventor Jillian Evans

Jillian Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
    Publication number: 20100068301
    Abstract: Disclosed herein are compositions and compounds that combine an inhibitor of 5-lipoxygenase activating protein (FLAP) and a modulator of NO levels in a mammal. The NO modulator can be an agent that induces the production of NO in a mammal, or can be an agent that itself produces NO in the mammal. Further disclosed herein are strategies for synthesizing such compounds, and methods for testing whether the combination compounds and compositions provide a desired benefit. Also disclosed herein are pharmaceutical compositions and formulations that combine a FLAP inhibitor and an NO modulator. Further described herein are methods for using such compositions and compounds for the treatment of diseases, conditions, and disorders in a mammal, including a human. Such treatment methods include the separate administration of a FLAP inhibitor and a NO modulator to the mammal, and the simultaneous administration of a FLAP inhibitor and a NO modulator to the mammal.
    Type: Application
    Filed: November 30, 2007
    Publication date: March 18, 2010
    Inventors: John H. Hutchinson, Mustapha Haddach, Mark Moran, Jillian Evans, Nicholas Simon Stock, Jeffrey Roger Roppe
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20070219206
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: May 4, 2007
    Publication date: September 20, 2007
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Brian Stearns, Jeffrey Roppe, Bowei Wang, Yen Truong, Yiwei Li, Jasmine Zunic, Jeannie Arruda, Nicholas Stock, Mustapha Haddach, Thomas Seiders, Jill Scott
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20070123522
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: October 4, 2006
    Publication date: May 31, 2007
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Jasmine Zunic, Nicholas Stock
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20070105866
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: October 27, 2006
    Publication date: May 10, 2007
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Yiwei Li, Jasmine Zunic, Jeannie Arruda, Nicholas Stock, Brian Stearns, Mustapha Haddach, Jeffrey Roppe